Optimizing Platelet-Rich Plasma (PRP) Injections: A Narrative Review
Biologic Orthopedics Journal · 2020
DOI: 10.22374/boj.v2i1.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologic Orthopedics Journal, 2020. Verfasst von Chris Cherian und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Platelet-rich plasma (PRP) is an orthobiologic treatment that has gained popularity as a potential alternative treatment for various musculoskeletal conditions. The physiologic role of platelets in the healing cascade provides clarity regarding its potential as it releases various growth factors such as platelet-derived growth factor (PDGF), transforming growth factor beta-1 (TGF-β1), and vascular endothelial growth factor (VEGF). However, there are various characteristics of PRP treatments including platelet count, presence or absence of leukocytes and red blood cells, as well as the use of an activating agent that introduces heterogeneity among preparations. This aim of this article is to provide clarity, where available, regarding the optimal characteristics for PRP treatments regarding tendon and ligament injuries as well as articular and muscular pathology.
Zitieren
APA
Cherian, C., Malanga, G., & Mautner, K. (2020). Optimizing Platelet-Rich Plasma (PRP) Injections: A Narrative Review. Biologic Orthopedics Journal. https://doi.org/10.22374/boj.v2i1.11
Vancouver
Cherian C, Malanga G, Mautner K. Optimizing Platelet-Rich Plasma (PRP) Injections: A Narrative Review. Biologic Orthopedics Journal. 2020. doi:10.22374/boj.v2i1.11
BibTeX
@article{Cherian2020,
author = {Cherian, Chris and Malanga, Gerard and Mautner, Ken},
title = {Optimizing Platelet-Rich Plasma (PRP) Injections: A Narrative Review},
journal = {Biologic Orthopedics Journal},
year = {2020},
doi = {10.22374/boj.v2i1.11}
}
EUVIMED